ASRA Division

ASRA Division of Hetero Healthcare was launched with a focused entry of biologics, addressing critical unmet needs in autoimmune diseases. Building on this strong foundation, the division has steadily expanded its portfolio across multiple drug classes to offer comprehensive solutions in rheumatology.

At Hetero Healthcare, we recognized key gaps in the management of autoimmune and musculoskeletal conditions and responded with innovative therapies across oral and injectable formulations. Today, the ASRA portfolio is designed to support holistic patient care, catering to rheumatologists and orthopedic, along with a robust range of supportive therapies.

Driven by innovation, quality, and patient-centricity, the ASRA Division continues to strengthen its commitment in the rheumatology segment with it’s strong product pipeline.

Therapy

View by-